AI Summary Zortress (everolimus) is an mTOR inhibitor used to prevent organ rejection after liver transplantation, often with reduced-dose tacrolimus or cyclosporine.
Medically reviewed.
Zortress (everolimus) is an oral immunosuppressive medication used to prevent organ rejection after liver transplantation. It belongs to the mTOR inhibitor class and is commonly used in combination regimens that allow lower doses of calcineurin inhibitors such as tacrolimus or cyclosporine. By calming the immune cells that could attack the transplanted liver, it helps protect the new liver and supports long-term graft function. Treatment decisions should always be individualized and guided by your transplant team.
This page covers Zortress's role after liver transplant — how it works, who may be prescribed it, how it is used, benefits, side effects, and monitoring. You can also connect with a liver specialist near you for personalized guidance on whether Zortress fits your care plan.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT ZORTRESS TREATMENT
Zortress is a prescription medicine that contains everolimus. It is an immunosuppressant, a medicine that lowers the activity of the immune system. Zortress is used to prevent organ rejection following liver transplantation.
Zortress belongs to a class of medicines called mTOR inhibitors, the same class as Rapamune (sirolimus). It has a shorter half-life than sirolimus, which means it leaves the body more quickly. Everolimus is also sold as Afinitor, which is used in cancer treatment rather than after transplant.
Zortress is commonly used as part of a combination of immunosuppressive medicines. It is usually taken with reduced-dose tacrolimus or cyclosporine, such as Prograf or Neoral / Gengraf. It is part of long-term care after transplant, which includes follow-up visits and regular laboratory testing.
WHO ZORTRESS MAY BE SUITABLE FOR
Zortress is used in people who have received a liver transplant and need maintenance immunosuppressive therapy. Maintenance therapy is the long-term treatment that protects the new liver from rejection.
Your transplant team may consider Zortress when they want to reduce your exposure to calcineurin inhibitors such as tacrolimus or cyclosporine. It may also be part of a combination plan to help preserve kidney function after transplant, or when your team is fine-tuning your long-term immunosuppressive regimen.
Because every patient's health profile is different, there is no one-size-fits-all answer to who should take Zortress. Your medical history, kidney function, transplant status, and other medications all factor into the decision. Treatment decisions should be made by your transplant team after a full assessment.
PRESCRIBING OVERVIEW
Zortress may be considered for people with the following situations or treatment goals:
Before recommending Zortress, your transplant team evaluates several factors to decide whether it is an appropriate option, including:
HOW ZORTRESS CAN HELP PROTECT YOUR NEW LIVER
Zortress blocks the mTOR pathway, a signaling route that immune cells use to grow and become active. By blocking it, Zortress limits the growth of T-lymphocytes and B-lymphocytes, two types of white blood cells that can drive rejection.
With less immune activity, there is less immune-mediated damage to the transplanted liver. Zortress works together with other immunosuppressants to prevent rejection. This teamwork lets your transplant team lower the dose of calcineurin inhibitors while still supporting long-term graft function. The graft is the transplanted liver.
Zortress is not used on its own. Your transplant team pairs it with other medicines and checks your blood levels, kidney function, and liver function at regular visits.
TRANSPLANT BENEFITS
Immune cells need a signaling route called the mTOR pathway to grow and become active. Zortress blocks this pathway, so fewer immune cells are ready to attack the transplanted liver. This is the core way the medicine works.
T-lymphocytes and B-lymphocytes are white blood cells that can drive rejection. Zortress limits how much they multiply. With fewer of these cells active, there is less immune-mediated damage to the transplanted liver.
Zortress is not used alone. It works synergistically with other immunosuppressants, which means the medicines combine their effects to help prevent rejection. Your transplant team chooses the combination that fits your situation.
Zortress is used as long-term maintenance therapy, so its role is to protect the graft, the transplanted liver, for years. Regular blood levels and liver function tests let your team confirm that the medicine is doing its job and keep your dose on track.
Zortress blocks the mTOR pathway to help prevent rejection and allows lower doses of calcineurin inhibitors. It should only be started and monitored under the guidance of your transplant team.
TREATMENT PROCESS
Zortress is supplied as oral tablets. Take it exactly as prescribed by your transplant team, and check with your pharmacist if you have any questions about your tablets.
The typical starting dose is 1 mg twice daily (2 mg a day in total). Your transplant team adjusts the dose based on your everolimus blood levels, kidney function, transplant status, and response to treatment.
Zortress is a tablet taken by mouth, with or without food. Take it at the same time each day and keep a consistent routine. It is usually prescribed together with reduced-dose tacrolimus or cyclosporine and other immunosuppressive medicines. Do not adjust your dose without medical guidance.
Zortress is generally used as long-term maintenance immunosuppressive therapy after liver transplantation. Treatment may continue for many years or for life, depending on how stable your transplant is, how well you tolerate the medicine, and your individual plan. Do not stop taking it without talking to your transplant team.
Store Zortress tablets at room temperature, away from moisture and heat.
Regular monitoring is required. Your transplant team checks your everolimus blood levels, kidney function, liver function, lipid profile (cholesterol and triglycerides), and blood counts. Report any side effects or unusual symptoms to your transplant team.
BENEFITS AND SAFETY
Zortress (everolimus) helps protect a transplanted liver by preventing rejection. It also allows your transplant team to use lower doses of calcineurin inhibitors such as tacrolimus or cyclosporine, which may reduce the risk of kidney damage. The extent of these benefits varies from person to person, depending on your transplant, kidney function, and how your body responds to treatment. Zortress is not a stand-alone treatment. It works best as part of a combination plan with regular blood tests and follow-up visits.
As with any medication, Zortress may cause side effects. These include high cholesterol or triglycerides, mouth sores, swelling in the legs or ankles, a higher risk of infection, and slower wound healing. Your transplant team will monitor you throughout treatment and adjust your plan as needed to balance benefits against risks.
BENEFITS
The main benefit of Zortress is rejection prevention. It helps protect the transplanted liver from immune attack, which is the goal of all post-transplant immunosuppression. How much protection you need depends on your transplant and how your body responds to treatment.
Zortress is part of a calcineurin reduction strategy. It allows lower exposure to tacrolimus or cyclosporine, so your transplant team can reduce the amount of these medicines in your regimen while the combination continues to protect your liver.
Lower calcineurin inhibitor exposure may reduce the risk of nephrotoxicity, which means damage to the kidneys caused by a medicine. For some people, this may help preserve kidney function after transplant. The benefit varies from person to person, so your team keeps checking your kidney function.
Zortress is effective in multi-drug regimens and is taken as an oral tablet. Your transplant team can combine it with other immunosuppressants and adjust the plan over time, guided by your blood levels and how you respond.
Tell your transplant team about any side effects you notice. Your team will discuss the potential benefits and risks before treatment and will monitor your blood levels, kidney function, liver function, cholesterol, and blood counts to help keep treatment safe.
SUPPORTING YOUR RESULTS
Daily habits are an important part of your care alongside Zortress. Taking your medicine consistently, protecting yourself from infection, and keeping every appointment all help keep your transplant and your treatment safe.
These habits can support how your body responds to treatment and help your transplant team catch problems early.
Areas that may support treatment:
Common Questions
Zortress may be prescribed to people who have received a liver transplant and need long-term maintenance immunosuppressive therapy. Your transplant team may consider it when they want to lower your exposure to tacrolimus or cyclosporine, help preserve kidney function, or fine-tune your long-term regimen. Your medical history, kidney function, and other medicines also matter. Only your transplant team can decide whether Zortress fits your situation, so talk with them about your goals and concerns.
Zortress helps prevent rejection by blocking the mTOR pathway, a signaling route that immune cells use to grow and become active. This limits the growth of T-lymphocytes and B-lymphocytes, white blood cells that can drive rejection, so there is less immune-mediated damage to the transplanted liver. It works together with other immunosuppressants. How well it works varies from person to person, so ask your transplant team how your treatment is going.
Both medicines contain everolimus, but they treat different conditions. Zortress is used to prevent organ rejection after liver transplantation. Afinitor is used in oncology to treat certain cancers by slowing cancer cell growth. Both belong to the mTOR inhibitor class, but your healthcare provider chooses the one that matches your condition and treatment plan. If you are unsure which medicine you have been prescribed, ask your transplant team or pharmacist to explain it.
Common side effects of Zortress include mouth sores, high cholesterol or triglycerides, swelling of the legs or ankles, a higher risk of infection, and slower wound healing. Your transplant team checks your everolimus blood levels, cholesterol, kidney function, and blood counts to help keep treatment safe. Tell your team about any side effects or unusual symptoms rather than stopping the medicine on your own.
No, you should avoid grapefruit products unless your healthcare provider approves them. Grapefruit can increase everolimus blood levels. Your transplant team checks these levels regularly and adjusts your dose based on them. Before you add any new food, supplement, or medicine, check with your transplant team or pharmacist. They can tell you what is safe to include in your routine while you take Zortress.
Zortress is generally used as long-term maintenance therapy after liver transplantation, and treatment may continue for many years or for life. The length depends on how stable your transplant is, how well you tolerate the medicine, and your individual plan. Take it at the same time each day, with or without food. Do not stop taking Zortress without talking to your transplant team, who can guide any changes.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
